MARKET IS CLOSED
Loading latest tickers...

Market Indices

S&P 500
$7,722.72
+0.73%
NASDAQ 100
$30,807.93
+1.00%
DOW JONES
$51,177.00
+0.49%
NASDAQ Composite
$27,190.86
+1.19%
RUSSELL 2000
$2,815.20
+0.90%
CBOE VIX
$15.31
-6.59%

Sector Heatmap

Technology+1.01%
Financials+0.06%
Healthcare-0.01%
Consumer Cycl+1.13%
Consumer Staples+0.25%
Energy+0.40%
Industrials+0.78%
Materials+0.66%
Real Estate+0.32%
Utilities+0.38%
Comm Services+0.35%

BMRN — BioMarin Pharmaceuticals Inc

Nasdaq

BioMarin Pharmaceuticals Inc

CompareBack to Screener
$57.18
-1.26(-2.16%)
O
58.52
H
58.73
L
57.15
V
2.19M
⏱️ End-of-day dataAs of Oct 2, 2026
OverviewStatisticsFinancialsHistorical DataOptionsDividend HistoryNewsChart

Chart

About BMRN

BioMarin is a global biotechnology company focused on developing and commercializing therapies for rare genetic diseases. BioMarin specializes in enzyme replacement therapies, gene therapies, and other advanced treatments designed to address complex genetic disorders. The company has eight approved therapies for conditions including achondroplasia, phenylketonuria, hemophilia, and mucopolysaccharidosis. BioMarin has an expanding, yet relatively early-stage, pipeline of treatments in development across skeletal conditions and enzyme therapies.

IndustryPHARMACEUTICAL PREPARATIONS
SectorNot available
IPO DateJul 23, 1999
Employees3,221
Stock ExchangeNasdaq
Ticker SymbolBMRN
Websitehttps://www.biomarin.com

Key Financial Statistics

Market Cap$11.66B
P/E RatioN/A
Dividend YieldNone
EPSN/A
BetaN/A
52-Week Range$49.26 - $70.98
52-Week Avg Volume2.28M
VWAP$57.56
Transactions31,884
Total Recorded Bars6,839 days